Open Access Open Access  Restricted Access Subscription or Fee Access

Electronic Patient Reported Outcomes significantly improved toxicity data collection and were acceptable to both patients and clinicians in lung cancer radiotherapy outpatient clinics.

Annalie Shears, Matthew Barker-Hewitt, Neil Bayman, Margaret Harris, Kate Haslett, Jason Kennedy, Lip Lee, Ben Wilson, Paul Taylor, Corinne Faivre

Abstract


Rationale: Toxicity after radiotherapy for lung cancer can be considerable and yet varies significantly between patients. In the future, it is hoped rapid learning techniques will be used to create decision support systems  that can determine individual patients’ outcomes and so help guide treatment choices accordingly. However, such research relies on the robust collection of prospective toxicity data. Electronic Patient Reported Outcomes (e-PROs) tools are an effective way of improving the quality and quantity of clinical data collection, yet there are currently none in routine use in UK lung cancer patients.

Methods: An e-PRO tool was designed to evaluate toxicity after lung cancer radiotherapy in outpatients at the Christie Hospital, Manchester, UK. Patients completed the e-PRO form on a tablet computer prior to consultation and both patients and clinicians completed feedback forms. e-PRO data was uploaded in real time to the electronic patient record. Subsequently, we evaluated the feasibility and acceptability of the use of the e-PRO tool and compared the completeness of toxicity recording with and without e-PROs.

Results: Eighty-seven patients completed e-PRO forms with 74 providing feedback. One hundred percent of patients were happy to complete e-PRO forms, 78.2% found the tablet easy to use and  71.5% felt that filling out e-PROs stimulated them to think of issues to discuss with the doctor. Sixty-eight feedback forms were returned by clinicians. One hundred percent used the PRO form and found it helpful, with 79.5% agreeing that it altered their consultation. The records of 38 patients who completed the e-PRO form were evaluated, this was a significant (p=0.0005) difference in toxicity recorded with and without the e-PRO form.

Conclusion: e-PROs are acceptable to patients and clinicians and improve the quality and quantity of clinical data collection. Future larger studies will need to validate these findings and assess the impact e-PROs have on decision-making and outcomes.


Keywords


ePRO, lung cancer, patient reported outcomes, person-centered healthcare, questionnaire, radiotherapy, tablet, toxicity

Full Text:

PDF

References


Vansteenkiste, J., De Ruysscher, D., Eberhardt, W.E., Lim, E., Senan, S., Felip, E., Peters, S. & ESMO Guidelines Working Group. (2013). Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 24 (Supplement 6) 89-98.

Chen, A.B., Cronin, A., Weeks, J.C., Chrischilles, E.A., Malin, J,, Hayman, J.A. & Schrag, D. (2013). Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. Journal of Clinical Oncology 31 (5) 558-564.

Dehing-Oberije, C., De Ruysscher, D., van Baardwijk, A., Yu, S., Rao, B. & Lambin, P. (2009). The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiotherapy & Oncology 91 (3) 421-426.

Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., Appawu, M., Iasonos, A., Atkinson, T., Goldfarb, S., Culkin, A., Kris, M.G. & Schrag, D. (2009). Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. Journal of the National Cancer Institute 101 (23) 1624-1632.

Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M.G., Scher, H.I. & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncology 7 (11) 903-909.

Christodoulou, M., McCloskey, P., Stones, N., Bayman, N., Burt, P., Chittalia, A., Harris, M., Lee, L., Pemberton, L., Sheikh, H., Swindell, R. & Faivtre-Finn, C. (2014). Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer. Radiotherapy and Oncology 112 (2) 244-249.

Velikova, G., Wright, E.P., Smith, A.B., Cull, A. Gould, A., Forman, D., Perren ,T., Stead, M., Brown, J. & Selby, P.J. (1999). Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires Journal of Clincical Oncology 17 (3) 998-1007.

Wintner, L.M., Giesinger, J.M., Zabernigg, A., Rumpold, G., Sztankay, M., Oberguggenberger, A.S., Gamper, E.M. & Holzner, B. (2015). Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at home. BMC Medical Informatics and Decision Making 15 (1) 110.

Dorman, P.J., Waddell, F., Slattery, J., Dennis, M. & Sandercock, P. (1997). Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased? Stroke 28 (10) 1883-1887.

Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., Appawu, A., Iasonos, A., Atkinson, T., Goldfarb, S., Culkin, A., Kris, M.G. & Schrag, D. (2009). Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. Journal of the Nattional Cancer Institute 101 (23)1624-1632.

Fromme, E.K., Eilers, K.M., Mori, M., Hsieh, Y.C. & Beer, B.M. (2004). How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. Journal of Clinical Oncology 22, 3485-3490.

Di Maio, M., Gallo, C., Leighl, N.B., et al. 2015). Symptomatic toxicities experienced during anticancer treatment : agreement between patient and physician reporting in three randomized trials. Journal of Clinical Oncology 33 (8) 910-915.

Basch, E. (2010). The missing voice of patients in drug-safety reporting. New England Journal of Medicine 362, 865-869.

Atkinson, T.M., Li, Y., Coffery, C.W., Sit, L., Shaw, M., Lavene, D., Bennett, A.V., Fruscione, M., Rogat, L., Hay, J., Gönen, M., Schrag, D. & Basch, E. (2012). Reliability of adverse symptom event reporting by clinicians. Quality of Life Research 21 (7) 1159-1164.

Basch, E., Reeve, B.B., Mitchell, S.A., et al. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute 106 (9) pii: dju244.




DOI: http://dx.doi.org/10.5750/ejpch.v5i2.1267

Refbacks

  • There are currently no refbacks.